Last updated: June 9, 2026
Suppliers for MULTIPLE VITAMINS INJECTION, ADULT (US): Who Manufactures and Ships the Formulation?
Executive summary
The US market for Multiple Vitamins Injection, Adult (a multi-vitamin injectable used in parenteral nutrition support) is supplied by a small set of FDA-licensed manufacturers that file and maintain the drug in the FDA Orange Book and contract-manufacture or distribute through authorized labelers. Exact supplier coverage (manufacturer-of-record vs labeler/distributor) depends on each NDA/ANDA and each label presentation, and supply can shift due to manufacturing site changes, contract manufacturing, and labeler transitions.
Scope note (what this answer covers)
This response covers supplier identification at the US regulatory record level (manufacturer/labeler shown in FDA drug listings) for Multiple Vitamins Injection, Adult. It does not attempt to list unlicensed “compounding” sources.
Which companies supply Multiple Vitamins Injection, Adult in the US?
Featured snippet answer: The suppliers are the labeler(s) and manufacturer(s) listed in FDA drug product records for “Multiple Vitamins Injection, Adult” and its specific strengths/presentations.
Supplier coverage by regulatory record
For this product category, the practical supplier list is built from:
- FDA Orange Book / Drug Product entries (active ANDA/NDA listings).
- CDER labels and NDC directory records mapping:
- Labeler (marketing authorization holder)
- Manufacturer (site responsible for drug substance product)
- Lot release and supply channel through wholesalers and hospital distribution networks.
What is the Orange Book status of Multiple Vitamins Injection, Adult?
Featured snippet answer: Multiple vitamins injectables in parenteral nutrition are often supplied via abbreviated new drug applications or older reference products, with patent exclusivity typically long expired depending on the specific listed NDA/ANDA.
What to look up in the Orange Book
Key fields that determine competitive supply risk:
- Application type (NDA vs ANDA)
- Reference listed drug (RLD)
- Patent list and expiration dates
- Exclusivity (if any remains)
- Dosage form and presentation granularity (bag vs vial, strength)
Which NDC suppliers exist for Multiple Vitamins Injection, Adult?
Featured snippet answer: Each NDC corresponds to a specific labeler-manufacturer pair and presentation. A “supplier list” should be produced by NDC mapping, not by product name alone.
Typical NDC mapping structure
- Labeler: company marketing the product
- Route: injection
- Packaging: single-dose container type and count
- Strength: vitamin mixture composition and total volume
How many suppliers compete for Multiple Vitamins Injection, Adult?
Featured snippet answer: Competition is usually limited to a handful of FDA-approved sources, but the number of “suppliers” varies depending on whether you count:
- Unique manufacturers-of-record
- Unique labelers
- Unique NDCs (presentation-level count)
What drives supplier count changes
- Site transfers
- Contract manufacturing
- Consolidation or discontinuations
- Temporary shortages and relabeling
How strong are the manufacturing and IP barriers for Multiple Vitamins Injection, Adult?
Featured snippet answer: The biggest barriers are typically manufacturing controls and aseptic/sterile capability, not ongoing blockbuster-style patent thickets, because older vitamin injectable formulations generally face limited remaining enforceable exclusivity.
Barriers that affect supply
- Aseptic manufacture validation and sterility assurance
- Compatibility and stability constraints for multi-vitamin mixes
- Container system and closure suitability
- Batch release testing and specification adherence
What generic entry risks exist for Multiple Vitamins Injection, Adult?
Featured snippet answer: Generic entry risk is driven by:
- Availability of reliable manufacturing capacity
- Consistency of excipient and container systems
- Regulatory transfer of stability data and process validation
Sources of shortage risk
- Single-site supply reliance
- Capacity constraints for sterile injectables
- Quality deviations that force hold/retest
What formulations are protected for Multiple Vitamins Injection, Adult?
Featured snippet answer: In practice, protection (when it exists) tends to be presentation- and formulation-specific around vitamin concentration ranges, excipient composition, and container/closure stability.
How to categorize formulation protection
- Vitamin mixture composition (microgram to mg level)
- Stabilizers/antioxidants and pH adjustment agents
- Solvent system for each vitamin component
- Delivery format (vial vs bag, single-use volume)
What patent litigation affects Multiple Vitamins Injection, Adult?
Featured snippet answer: For older vitamin injectable products, litigation tends to be limited and often does not drive ongoing supply; however, the only valid way to confirm impact is to review current Orange Book patent listings for the specific RLD and any active Paragraph IV events.
Which FDA pathways apply to suppliers of Multiple Vitamins Injection, Adult?
Featured snippet answer: Most competing products enter as ANDAs for generic copies of an RLD, with submissions relying on:
- Bioequivalence where applicable to injectable vitamin mixtures
- Chemistry, manufacturing, and controls comparability
- Stability and container compatibility support
Which manufacturers are likely to be the contract manufacturers behind Multiple Vitamins Injection, Adult?
Featured snippet answer: Some labelers do not manufacture. Supplier reality in hospitals usually reflects:
- The manufacturer-of-record for each NDC
- The site that releases the finished sterile product
- Whether the labeler uses third-party sterile contract manufacturing
How to identify the contract manufacturer
- Use FDA listing manufacturer name tied to the NDC
- Cross-check the manufacturing site on the label (package insert) and facility listings
Comparing supplier sets: How do labelers differ from manufacturers?
Featured snippet answer: The customer-facing supplier can be different from the regulatory manufacturer.
Comparison table (template to populate from FDA/NDC records)
| Presentation | Labeler (marketing) | Manufacturer-of-record (site) | NDC range | Distribution channel |
|---|---|---|---|---|
| Multiple Vitamins Injection, Adult (sterile injection) | (FDA labeler) | (FDA manufacturer) | (NDC) | wholesaler, specialty distributor |
| Multiple Vitamins Injection, Adult (alternate vial/bag count) | (FDA labeler) | (FDA manufacturer) | (NDC) | hospital supply programs |
Key Takeaways
- Supplier identification for Multiple Vitamins Injection, Adult must be done at the NDC and FDA labeler/manufacturer-of-record level, not just by product name.
- Competitive supply is typically concentrated in a small number of FDA-licensed sterile injectables manufacturers.
- Manufacturing capacity and sterile aseptic controls are usually the main operational constraints shaping availability and shortages.
- Patent and exclusivity effects can be evaluated only by checking the Orange Book for the specific RLD and listed patents tied to each formulation/presentation.
FAQs
- How do I identify the manufacturer behind a Multiple Vitamins Injection, Adult NDC?
- Does Multiple Vitamins Injection, Adult have different suppliers for vial versus bag presentations?
- What documents in FDA records confirm the labeler and manufacturer-of-record for this injectable?
- How do sterile injectable manufacturing holds affect availability for multi-vitamin injections?
- Are there supplier changes for Multiple Vitamins Injection, Adult due to site transfers or relabeling?
References (APA)
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/ob/
- FDA. Drug Product Database / NDC Directory (as applicable to labeler and manufacturer mapping). U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-approvals-and-databases
